Home › Trial NCT01661335
Efficacy of Aprepitant (Emend®) in Children
- Trial IDNCT01661335
- StatusCompleted
- PhasePhase 3
- Study typeInterventional
- SponsorUniversity of Oklahoma
- Enrollment19
- Start date2012-06-01
- ConditionsNausea · Vomiting · Childhood Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.